Ironwood Capital

Torigen Pharmaceuticals is a company dedicated to advancing cancer care solutions for companion animals. Founded in 2013 by Ashley Kalinauskas and Mark Suckow, the company is based in Farmington, Connecticut. Torigen focuses on developing innovative immunotherapy treatments, including an experimental autologous cancer vaccine that activates the immune system to target specific tumor-associated antigens on cancer cells. This approach aims to enable veterinarians to detect and treat cancer in animals more effectively, reducing the reliance on invasive surgeries and chemotherapy. By leveraging existing scientific research, Torigen seeks to improve outcomes for pets diagnosed with cancer, enhancing their quality of life through novel therapeutic strategies.

P2 Science, Inc. is a bio-renewable chemistry company based in Woodbridge, Connecticut, that specializes in developing and producing specialty chemicals derived from renewable feedstocks, such as vegetable oils. Founded in 2009 by a team including Yale scientists, P2 Science has created innovative process technologies that transform these sustainable materials into high-value products, including ingredients for flavors, fragrances, and cosmetics, which are traditionally sourced from petrochemicals. The company's offerings cater to various industries, including household and industrial cleaning, personal care, agriculture, environmental remediation, and more. P2 Science aims to support businesses in decarbonizing the chemical industry by providing renewable alternatives to conventional petrochemical ingredients. With a laboratory in New Haven, the company collaborates with major partners across the supply chain to further enhance its technology and market reach.

IsoPlexis is a life science technology company based in Branford, Connecticut, established in 2013. It specializes in developing a single-cell detection system that identifies a wide array of patient immune responses at the single-cell level. The company's platform focuses on cell-based proteomic systems and biomarkers, allowing for the assessment of therapeutic safety and efficacy, monitoring of disease progression, and exploration of functional protein biology and cellular signaling networks. IsoPlexis's technology enables clients to predict cancer patient responses to various novel immunotherapies and cellular therapies, thereby enhancing therapeutic development and informing clinical decision-making.

PayVeris, LLC is a cloud-based digital payment and money transfer platform that provides comprehensive solutions for both consumer and business bill payments, as well as external account-to-account transfers between various financial institutions. Founded in 2011 and headquartered in Cromwell, Connecticut, PayVeris enables person-to-person payments, allowing users to send money electronically from their bank or credit union accounts via web, smartphone, or tablet. The platform includes PayWatch, an integrated fraud prevention solution that monitors transactions for potential risks, and PayItNow, a service that connects financial institutions, merchants, and consumers in the payments process. PayVeris has established strategic partnerships with Kony and Corelation to enhance its offerings and expand its reach in the digital payments landscape.

IsoPlexis is a life science technology company based in Branford, Connecticut, established in 2013. It specializes in developing a single-cell detection system that identifies a wide array of patient immune responses at the single-cell level. The company's platform focuses on cell-based proteomic systems and biomarkers, allowing for the assessment of therapeutic safety and efficacy, monitoring of disease progression, and exploration of functional protein biology and cellular signaling networks. IsoPlexis's technology enables clients to predict cancer patient responses to various novel immunotherapies and cellular therapies, thereby enhancing therapeutic development and informing clinical decision-making.

IsoPlexis is a life science technology company based in Branford, Connecticut, established in 2013. It specializes in developing a single-cell detection system that identifies a wide array of patient immune responses at the single-cell level. The company's platform focuses on cell-based proteomic systems and biomarkers, allowing for the assessment of therapeutic safety and efficacy, monitoring of disease progression, and exploration of functional protein biology and cellular signaling networks. IsoPlexis's technology enables clients to predict cancer patient responses to various novel immunotherapies and cellular therapies, thereby enhancing therapeutic development and informing clinical decision-making.

P2 Science, Inc. is a bio-renewable chemistry company based in Woodbridge, Connecticut, that specializes in developing and producing specialty chemicals derived from renewable feedstocks, such as vegetable oils. Founded in 2009 by a team including Yale scientists, P2 Science has created innovative process technologies that transform these sustainable materials into high-value products, including ingredients for flavors, fragrances, and cosmetics, which are traditionally sourced from petrochemicals. The company's offerings cater to various industries, including household and industrial cleaning, personal care, agriculture, environmental remediation, and more. P2 Science aims to support businesses in decarbonizing the chemical industry by providing renewable alternatives to conventional petrochemical ingredients. With a laboratory in New Haven, the company collaborates with major partners across the supply chain to further enhance its technology and market reach.

Precipio Diagnostics is a cancer diagnostics company based in New Haven, Connecticut, specializing in clinical diagnostic services for hematopoietic cancers. The company offers advanced diagnostic products, including the HemeScreen panel for genetic mutation testing and the IV-Cell media, which enhances the accuracy of laboratory results. Precipio serves a diverse clientele, including oncologists, hospitals, reference laboratories, and pharmaceutical companies. In its commitment to improving cancer care, the company collaborates with prominent academic institutions such as the Yale School of Medicine and Dana-Farber Cancer Institute, fostering connections between physicians and leading pathologists. With laboratories in New Haven and Omaha, Precipio aims to reduce instances of cancer misdiagnoses and provide essential diagnostics to oncologists across the United States.

PayVeris, LLC is a cloud-based digital payment and money transfer platform that provides comprehensive solutions for both consumer and business bill payments, as well as external account-to-account transfers between various financial institutions. Founded in 2011 and headquartered in Cromwell, Connecticut, PayVeris enables person-to-person payments, allowing users to send money electronically from their bank or credit union accounts via web, smartphone, or tablet. The platform includes PayWatch, an integrated fraud prevention solution that monitors transactions for potential risks, and PayItNow, a service that connects financial institutions, merchants, and consumers in the payments process. PayVeris has established strategic partnerships with Kony and Corelation to enhance its offerings and expand its reach in the digital payments landscape.

The Green Life Guides, LLC operates an online site for wedding ideas, products, and services. Its products and services include business cards, live events, food and flowers, and service directory for vendors; products and gifts for weddings, bar mitzvahs, and holidays; living room furniture; table linens and flatware; appliances and electronics, baking, cleaning supplies, cookware, and cutting boards; baskets, rugs, candles and candle holders, centerpieces, curtains, and hardware; organization and storage products; blankets, quilts, duvets, sheets, mattresses, pillows, and accents; towels, bathroom accessories, rugs and mats, shower curtains, and personal care and beauty products; garden accessories, composters, and plants and seeds; and dog and cat supplies. The company was founded in 2007 and is based in New Haven, Connecticut.

Floop, Inc. operates as a mobile application that offers real time graphical interface. The company was incorporated in 2010 and is based in Woodbridge, Connecticut.

NovaTract Surgical, Inc. is a medical device company dedicated to enhancing minimally invasive surgical practices. Founded in 2010 and based in Madison, Connecticut, the company specializes in developing innovative solutions such as the NovaGrasp, a single-use laparoscopic grasper for tissue and organ retraction, and the NovaTract, a dynamic retractor designed for various surgical fields including colorectal, urologic, gynecologic, and robotic-assisted procedures. NovaTract Surgical aims to address the needs of the rapidly evolving fields of single-incision laparoscopic surgery and natural orifice transluminal endoscopic surgery, providing healthcare institutions with advanced tools to improve surgical outcomes.